469 results on '"Epidermal growth factor -- Research -- Reports"'
Search Results
2. Findings from National Research Ogarev Mordovia State University in the Area of Non-Small Cell Lung Cancer Described [Covalent Epidermal Growth Factor Receptor (Egfr) Inhibitors In Targeted Therapy of Drug-resistant Non-small Cell Lung Cancer (A ...]
3. New Lung Cancer Study Findings Have Been Reported by Investigators at Hassan II University of Casablanca (Design and Optimization of Quinazoline Derivatives As Potent Egfr Inhibitors for Lung Cancer Treatment: a Comprehensive Qsar, Admet, and ...)
4. New Colon Cancer Study Findings Have Been Reported by a Researcher at Bandirma Onyedi Eylul University [Epidermal Growth Factor Downregulates Carbon Anhydrase III (CAIII) in Colon Cancer]
5. Studies Conducted at Nanjing University on Apoptosis Recently Published (MDM2 drives resistance to Osimertinib by contextually disrupting FBW7-mediated destruction of MCL-1 protein in EGFR mutant NSCLC)
6. Recent Findings in Liver Cancer Described by Researchers from Henan University People's Hospital (Machine learning based ultrasomics noninvasive predicting EGFR expression status in hepatocellular carcinoma patients)
7. Research from West Virginia University Has Provided New Study Findings on Non-Small Cell Lung Cancer (ERO1A levels are a prognostic indicator in EGFR mutated non small cell lung cancer)
8. New Receptor Protein-Tyrosine Kinases Research Has Been Reported by Researchers at Fudan University [Nuclear epidermal growth factor receptor (nEGFR) in clinical treatment]
9. Recent Findings in Lung Cancer Described by Researchers from Chungnam National University (Paeoniae Radix Overcomes Resistance To Egfr-tkis Via Aurora B Pathway Suppression In Lung Adenocarcinoma)
10. Findings from University of Colorado Broaden Understanding of Non-Small Cell Lung Cancer [Tyrosine Kinase Inhibitors With and Without Up-front Stereotactic Radiosurgery for Brain Metastases From egfr and alk Oncogene
11. Recent Findings from Seoul National University Provides New Insights into Cancer [A Phase Ii Study of Osimertinib In Patients With Nsclc Harboring Egfr Exon 20 Insertion: a Multicenter Trial of the Korean Cancer Study Group (Lu17-19)2 2]
12. New Non-Small Cell Lung Cancer Study Findings Have Been Reported from Yonsei University College of Medicine (BLU-945, a potent and selective next-generation EGFR TKI, has antitumor activity in models of osimertinib-resistant non-small-cell lung ...)
13. Researchers at University of Oulu Publish New Data on Colon Cancer (Ubiquitin-specific protease 10 determines colorectal cancer outcome by modulating epidermal growth factor signaling via inositol polyphosphate-4-phosphatase type IIB)
14. Investigators at Princess Margaret Cancer Centre Report Findings in Kinase Inhibitors (Osimertinib In Stage Iii egfr-mutated Nsclc - Game, Set, Match)
15. East Carolina University Researchers Highlight Recent Research in Neuroblastomas (Reduction of N-Acetylglucosaminyltransferase-I Activity Promotes Neuroblastoma Invasiveness and EGF-Stimulated Proliferation In Vitro)
16. New Lung Cancer Study Findings Have Been Reported by Researchers at Ministry of Health (Epidermal Growth Factor Receptor-mutated Lung Carcinomas With Insufficient Response To Epidermal Growth Factor Receptor Inhibitors)
17. New Findings on Non-Small Cell Lung Cancer from University of Malaya Summarized (Real-world Efficacy of Low Dose Osimertinib As Second-line Treatment In Patients With Epidermal Growth Factor Receptor-mutated Advanced Non-small Cell Lung Cancer)
18. New Cancer Findings from King Saud University Described [Dissolution Enhancement of Gefitinib By Solid Dispersion and Complexation With (3-cyclodextrins: In Vitro Testing, Cytotoxic Activity, and Tablet Formulation]
19. Report Summarizes Cancer Study Findings from Faculty of Pharmacy (Review on EGFR-ERK1/2 signaling cascade: implications on cell proliferation in health and disease)
20. New Non-Small Cell Lung Cancer Study Findings Recently Were Published by a Researcher at Soroka Medical Center (Adverse Events in Osimertinib Treatment for EGFR-Mutated Non-Small-Cell Lung Cancer: Unveiling Rare Life-Threatening Myelosuppression)
21. New Findings in Cancer Described from Michigan State University (EGFR- and Integrin a [ [V] ] b [ [3] ] -Targeting Peptides as Potential Radiometal-Labeled Radiopharmaceuticals for Cancer Theranostics)
22. Kaiser Permanente Northern California Researcher Publishes New Data on Peptide Receptors (Impact of pharmacist managed oral epidermal growth factor receptor inhibitors)
23. Researchers from University of Calcutta Publish Findings in Breast Cancer (Identification of potential therapeutic dual inhibitors of EGFR/HER2 in breast cancer)
24. Findings in the Area of Salivary Gland Cancer Reported from Kobe University (Differential Expression of Epidermal Growth Factor Receptor In Various Pathological Types of Salivary Gland Cancers)
25. Research from Achucarro Basque Center for Neuroscience Provide New Insights into Seizures (HB-EGF activates EGFR to induce reactive neural stem cells in the mouse hippocampus after seizures)
26. Findings from Department of Pharmacy Yields New Findings on Personalized Medicine (Functional Role of Dusp6 In the Egfr-mediated Progression of Head and Neck Squamous Cell Carcinoma)
27. Researcher's Work from National Cheng Kung University Hospital Focuses on Metastatic Breast Cancer (The Real-world Experiences of Abemaciclib for Estrogen Receptor-positive Human Epidermal Growth Factor Receptor-negative-2 Metastatic Breast ...)
28. Researcher from University of Memphis Provides Details of New Studies and Findings in the Area of Lung Cancer (Prevalence of Epidermal Growth Factor Receptor and Programmed Death Ligand 1 Testing in a Population-Based Lung Cancer Surgical ...)
29. Sungkyunkwan University School of Medicine Researchers Provide Details of New Studies and Findings in the Area of Non-Small Cell Lung Cancer [Lazertinib versus Platinum-Based Chemotherapy with Epidermal Growth Factor Receptor (EGFR)-Positive ...]
30. Studies from Children's Hospital Have Provided New Information about Breast Cancer [Human Epidermal Growth Factor Receptor 2 (Her2) Status In Breast Cancer: Practice Points and Challenges]
31. Investigators at University of Malaya Report Findings in Non-Small Cell Lung Cancer [Does Dose Reduction of Afatinib Affect Treatment Outcomes of Patients With egfr-mutant Metastatic Non-small Cell Lung Cancer In Real-world Clinical
32. New Study Findings from Univerzitet u Beogradu Illuminate Research in Breast Cancer (Bone metastases of breast cancer: The influence of hormone receptors and human epidermal growth factor receptor 2)
33. Researchers from University of Wollongong Detail Findings in Gastric Cancer (EGFR and PI3K Signalling Pathways as Promising Targets on Circulating Tumour Cells from Patients with Metastatic Gastric Adenocarcinoma)
34. Research from Cantonal Hospital Reveals New Findings on Lung Cancer (Prolonged Response to Afatinib and Crizotinib in a Rare Case of EGFR-, HER2-, MET- and ROS1-Alterated Lung Adenocarcinoma)
35. Reports on Lung Cancer Findings from Central South University Provide New Insights (b-Elemene Reverses Gefitinib Resistance in NSCLC Cells by Inhibiting lncRNA H19-Mediated Autophagy)
36. University Hospital Modena Researcher Provides New Study Findings on Non-Small Cell Lung Cancer (Management of oligometastatic and oligoprogressive epidermal growth factor receptor mutated non-small cell lung cancer patients: state of the art ...)
37. Investigators at Fudan University Report Findings in Non-Small Cell Lung Cancer (Efficient 18f-fluorodeoxyglucose Positron Emission Tomography/computed Tomography-based Machine Learning Model for Predicting Epidermal Growth Factor Receptor ...)
38. Findings in Cancer Reported from Nara Medical University (Role of Epiregulin on Lipopolysaccharide-Induced Hepatocarcinogenesis as a Mediator via EGFR Signaling in the Cancer Microenvironment)
39. Recent Findings in Breast Cancer Described by a Researcher from University of Louisville School of Medicine (Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Expression Rates in Invasive Breast Carcinoma: A ...)
40. Shandong First Medical University Researchers Provide New Study Findings on Brain Metastasis (Clinical characteristics and MRI based radiomics nomograms can predict iPFS and short-term efficacy of third-generation EGFR-TKI in EGFR-mutated lung ...)
41. Researcher at Cedars Sinai Medical Center Details Research in Non-Small Cell Lung Cancer (Early dose reduction of osimertinib in advanced EGFR-mutated non-small cell lung cancer)
42. Report Summarizes Chemotherapy Study Findings from Takeda Development Center Americas Inc. (Mobocertinib: Mechanism of action, clinical, and translational science)
43. New Findings from National Autonomous University of Mexico (UNAM) in the Area of Ibuprofen Therapy Described (Compounds Consisting of Quinazoline, Ibuprofen, and Amino Acids With Cytotoxic and Anti-inflammatory Effects)
44. Findings from Chinese Academy of Medical Sciences Provide New Insights into Lung Cancer (Improved Prediction of Epidermal Growth Factor Receptor Status by Combined Radiomics of Primary Nonsmall-Cell Lung Cancer and Distant Metastasis)
45. New Non-Small Cell Lung Cancer Findings from S.G. Moscati Hospital Described (The Role of Adjuvant Chemotherapy before Osimertinib in Epidermal Growth Factor Receptor Mutant Resected Non-Small Cell Lung Cancer and Communicating It to Patients)
46. Reports Outline Non-Small Cell Lung Cancer Study Findings from Columbia University (Cutaneous Toxicities With Amivantamab for Non-small Cell Lung Cancer: a Practical Guide and Best Practices)
47. Study Results from Jinan University in the Area of Non-Small Cell Lung Cancer Published (Shikonin induces the apoptosis and pyroptosis of EGFR-T790M-mutant drug-resistant non-small cell lung cancer cells via the degradation of cyclooxygenase-2)
48. Studies from Wenling Add New Findings in the Area of Lung Cancer (15-Deoxy-D-12,14-Prostaglandin J2 Represses Immune Escape of Lung Adenocarcinoma by Polarizing Macrophages Through Epidermal Growth Factor Receptor/Ras/Raf Pathway)
49. Data from Wuhan University Broaden Understanding of Vaccines (Rational Design of an Epidermal Growth Factor Receptor Vaccine: Immunogenicity and Antitumor Research)
50. New Findings in Receptor Protein-Tyrosine Kinases Described from Department of Research (Epidermal growth factor receptor ligands enriched in follicular fluid exosomes promote oncogenesis of fallopian tube epithelial cells)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.